Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Go back to Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs| (NASDAQ: JAGX) | Delayed: 2.71 -0.04 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.75 | 52 Week High | $4.60 | |||
| Open | $2.76 | 52 Week Low | $0.81 | |||
| Day High | $3.16 | P/E | N/A | |||
| Day Low | $2.65 | EPS | $0.00 | |||
| Volume | 233,792 | |||||
